-
1
-
-
0024348344
-
Clinical experience with lisinopril. Observations on safety and tolerability
-
Cameron HA Higgins TJ Clinical experience with lisinopril. Observations on safety and tolerability J Hum Hypertens 1989 3 Suppl. 1 177 86
-
(1989)
J Hum Hypertens
, vol.3
, Issue.1 SUPPL.
, pp. 177-86
-
-
Cameron, H.A.1
Higgins, T.J.2
-
2
-
-
0031047155
-
Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema
-
Sabroe RA Black AK Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema Br J Dermatol 1997 136 153 8
-
(1997)
Br J Dermatol
, vol.136
, pp. 153-8
-
-
Sabroe, R.A.1
Black, A.K.2
-
3
-
-
33644781431
-
-
The Department of Pharmacoepidemiology NIoPH, Norwegian Institute of Public Health. Drug Consumption in Norway
-
The Department of Pharmacoepidemiology NIoPH, Norwegian Institute of Public Health. Drug Consumption in Norway URL 2005
-
(2005)
-
-
-
4
-
-
1342347474
-
Angiotensin-converting enzyme inhibitor related angioedema and the anaesthetist
-
Rai MR Amen F Idrees F Angiotensin-converting enzyme inhibitor related angioedema and the anaesthetist Anaesthesia 2004 59 283 9
-
(2004)
Anaesthesia
, vol.59
, pp. 283-9
-
-
Rai, M.R.1
Amen, F.2
Idrees, F.3
-
5
-
-
4444225379
-
Hereditary and acquired angioedema: Problems and progress. Proceedings of the Third C1 Esterase Inhibitor Deficiency Workshop and Beyond
-
Agostoni A Ygoren-Pursun E Binkley KE et al. Hereditary and acquired angioedema: problems and progress. Proceedings of the Third C1 Esterase Inhibitor Deficiency Workshop and Beyond J Allergy Clin Immunol 2004 114 S51 131
-
(2004)
J Allergy Clin Immunol
, vol.114
, pp. 51-131
-
-
Agostoni, A.1
Ygoren-Pursun, E.2
Binkley, K.E.3
-
7
-
-
3242881814
-
A response to 'Angiotensin-converting enzyme inhibitor related angioedema and the anaesthetist', Rai M R, Amen F and Idrees F, Anaesthesia 2004; 59: 283-9
-
Bhatia A Smith H Trivedi M A response to 'Angiotensin-converting enzyme inhibitor related angioedema and the anaesthetist', Rai M R, Amen F and Idrees F, Anaesthesia 2004; 59: 283-9 Anaesthesia 2004 59 732 3
-
(2004)
Anaesthesia
, vol.59
, pp. 732-3
-
-
Bhatia, A.1
Smith, H.2
Trivedi, M.3
-
9
-
-
0024258118
-
Angioneurotisches Ödem unter ACE-Hemmern: Häufigkeit, klinische Charakeristik, Auslösemechanismen
-
Wernze H Angioneurotisches Ödem unter ACE-Hemmern: Häufigkeit, klinische Charakeristik, Auslösemechanismen Z Kardiol 1988 77 61 4
-
(1988)
Z Kardiol
, vol.77
, pp. 61-4
-
-
Wernze, H.1
-
10
-
-
0025851774
-
Contraindications to the use of ACE inhibitors in patients with C1 esterase inhibitor deficiency (letter)
-
Agostoni A Cicardi M Contraindications to the use of ACE inhibitors in patients with C1 esterase inhibitor deficiency (letter) Am J Med 1991 90 278
-
(1991)
Am J Med
, vol.90
, pp. 278
-
-
Agostoni, A.1
Cicardi, M.2
-
11
-
-
0022503042
-
The blocking by human C1-inactivator of both carrageenin paw edema and its potentiation by the angiotensin converting enzyme-inhibitor ramipril
-
Caspritz G The blocking by human C1-inactivator of both carrageenin paw edema and its potentiation by the angiotensin converting enzyme-inhibitor ramipril IRCS Med Sci 1986 14 568 9
-
(1986)
IRCS Med Sci
, vol.14
, pp. 568-9
-
-
Caspritz, G.1
-
12
-
-
0034781881
-
C1-esterase-inhibitor during angioneurotic oedema of the tongue caused by angiotensin converting enzyme inhibitors
-
Steinbach O Schweder R Freitag B C1-esterase-inhibitor during angioneurotic oedema of the tongue caused by angiotensin converting enzyme inhibitors Anaesthesiol Reanim 2001 26 133 7
-
(2001)
Anaesthesiol Reanim
, vol.26
, pp. 133-7
-
-
Steinbach, O.1
Schweder, R.2
Freitag, B.3
-
13
-
-
0036122075
-
Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor
-
Han ED MacFarlane RC Mulligan AN Scafidi J Davis AE III. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor J Clin Invest 2002 109 1057 63
-
(2002)
J Clin Invest
, vol.109
, pp. 1057-63
-
-
Han, E.D.1
MacFarlane, R.C.2
Mulligan, A.N.3
Scafidi, J.4
Davis Iii., A.E.5
-
14
-
-
10244240479
-
Icatibant: HOE 140, JE 049, JE049
-
Icatibant: HOE 140, JE 049, JE049 Drugs R D 2004 5 343 8
-
(2004)
Drugs R D
, vol.5
, pp. 343-8
-
-
|